Definitive Contract W911QY20C0110
Award Date
9/26/20
Potential Completion Date
3/5/21
Potential Value
$921K
Funding Federal Agency
Joint PEO Chemical and Biological Defense
Contracting Federal Agency
ACC Aberdeen Proving Ground
Awardee
Visby Medical, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95134, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Visby Medical, Inc. was awarded a definitive contract valued at $9.5 million by the National Institutes of Health's National Heart Lung and Blood Institute to deliver a single-use, fully-integrated, rapid, automated reverse transcription polymerase chain reaction in vitro diagnostic test. The contract is associated with the Rapid Acceleration of Diagnostics program and will support Visby Medical's development and delivery of its rapid point-of-care COVID-19 diagnostic test. Work will be...
This is a $52,239,640.00 definitive contract awarded to Visby Medical, Inc. by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. The contract is for the delivery of a rapid, accurate, point-of-care disposable influenza and SARS-CoV-2 molecular diagnostic test. This award is not set aside for any particular business classification. The contract has an ultimate completion date of March 31, 2026. The original solicitation was issued...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $12.8 million firm fixed price purchase order to Cepheid, a subsidiary of Danaher Corporation, for XPRSARS-COV2-10 TESTS. The contract is being funded by the Army to support the national interest in response to the Coronavirus COVID-19 and will provide Cepheid's coronavirus tests. Performance will occur in Sunnyvale, California over a 10 month period concluding in March 2021. No...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $41.2 million firm fixed price definitive contract to Cepheid, a subsidiary of Danaher Corporation, for the purchase of Cepheid GeneXpert Systems and COVID-19 assays. The contract supports the agency's response to the Coronavirus COVID-19 national interest by providing molecular diagnostic testing platforms and tests to detect SARS-CoV-2, the virus that causes COVID-19. Performance will take...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $5.9 million firm fixed price delivery order to Biofire Defense LLC. The order is for the purchase of COVID-19 assays, external control materials, and software module updates to support the agency's response to the Coronavirus pandemic. Performance will take place in Salt Lake City, Utah, through December 2020. No set aside designation or subcontractors were indicated. The funding agency...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $262,265 delivery order to Cepheid, a subsidiary of Danaher Corporation, to support COVID-19 response efforts. The firm fixed price order is being performed under the National Interest Action Code for Coronavirus at Fort Liberty, North Carolina through October 2021. The contract calls for Cepheid to provide products and services in support of the Army's $000 major program for chemical and...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $120,192 delivery order to ANP Technologies Inc. to provide SARS-COV-2 lateral flow immunoassay kits. The contract supports the Army's coronavirus COVID-19 response efforts. Performance will occur in Newark, Delaware over a one-month period concluding in mid-July 2020. Pricing is set at firm fixed rates. No subcontractors or set aside designations were indicated. The award draws on the...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Program Phase I action contract to Visby Medical, Inc., a for-profit medical diagnostics manufacturer. The $140,000.00 firm-fixed-price contract, which was set aside for small businesses, is for the development of a rapid, accurate point-of-care diagnostic test under SBIR Topic 075. Visby Medical has received...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $12 million firm fixed price delivery order to Cepheid, a subsidiary of Danaher Corporation, to support its XPCOV2/FLU/RSV-10 program. The contract calls for Cepheid to provide products and services for the detection of COVID-19, influenza, and respiratory syncytial virus from a single patient sample at its place of performance in Aberdeen, Maryland. The period of performance is from...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $1,312,325 firm fixed price delivery order contract to Cepheid, a subsidiary of Danaher Corporation, to provide XPCOV2/FLU/RSV-10 tests. The contract will be performed in Aberdeen, Maryland from January 11, 2022 through March 4, 2022 in support of the Coronavirus COVID-19 national interest. Cepheid will supply its tests for the SARS-CoV-2, influenza, and respiratory syncytial virus pathogens...